Literature DB >> 26274841

Density-Dependent Metabolic Heterogeneity in Human Mesenchymal Stem Cells.

Yijun Liu1, Nathalie Muñoz2, Bruce A Bunnell3, Timothy M Logan2,4, Teng Ma1,2.   

Abstract

Human mesenchymal stem cells (hMSCs) are intrinsically heterogeneous and comprise subpopulations that differ in their proliferation, multi-potency, and functional properties, which are commonly demonstrated by culturing hMSCs at different plating densities. The objective of this study was to investigate the metabolic profiles of different subpopulations of hMSC by testing the hypothesis that the clonogenic hMSC subpopulation, which is selectively enriched in clonal density (CD) and low density (LD) culture (10 and 100 cells per square centimeter, respectively), possesses a metabolic phenotype that differs from that of hMSC in medium- or high-density (MD: 1,000 and HD: 3,000 cells per square centimeter, respectively). Cells at CD and LD conditions exhibited elevated expression of CD146 and colony forming unit-fibroblast compared with cells at MD- or HD. Global metabolic profiles revealed by gas chromatography-mass spectrometry of cell extracts showed clear distinction between LD and HD cultures, and density-dependent differences in coupling of glycolysis to the TCA cycle. Metabolic inhibitors revealed density-dependent differences in glycolysis versus oxidative phosphorylation (OXPHOS) for ATP generation, in glutamine metabolism, in the dependence on the pentose phosphate pathway for maintaining cellular redox state, and sensitivity to exogenous reactive oxygen species. We also show that active OXPHOS is not required for proliferation in LD culture but that OXPHOS activity increases senescence in HD culture. Together, the results revealed heterogeneity in hMSC culture exists at the level of primary metabolism. The unique metabolic characteristics of the clonogenic subpopulation suggest a novel approach for optimizing in vitro expansion of hMSCs.
© 2015 AlphaMed Press.

Entities:  

Keywords:  Cellular proliferation; Cellular therapy; Hypoxia; Mesenchymal stem cells

Mesh:

Year:  2015        PMID: 26274841      PMCID: PMC4757908          DOI: 10.1002/stem.2097

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  63 in total

1.  Human mesenchymal stem cells tissue development in 3D PET matrices.

Authors:  Warren L Grayson; Teng Ma; Bruce Bunnell
Journal:  Biotechnol Prog       Date:  2004 May-Jun

Review 2.  Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions.

Authors:  Darwin J Prockop; Scott D Olson
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

Review 3.  Concise review: Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic.

Authors:  Jennifer J Bara; R Geoff Richards; Mauro Alini; Martin J Stoddart
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

4.  Low ATP level is sufficient to maintain the uncommitted state of multipotent mesenchymal stem cells.

Authors:  L B Buravkova; Y V Rylova; E R Andreeva; A V Kulikov; M V Pogodina; B Zhivotovsky; V Gogvadze
Journal:  Biochim Biophys Acta       Date:  2013-06-04

5.  Increased pentose phosphate pathway flux after clinical traumatic brain injury: a [1,2-13C2]glucose labeling study in humans.

Authors:  Joshua R Dusick; Thomas C Glenn; W N Paul Lee; Paul M Vespa; Daniel F Kelly; Stefan M Lee; David A Hovda; Neil A Martin
Journal:  J Cereb Blood Flow Metab       Date:  2007-02-07       Impact factor: 6.200

6.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

7.  Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions.

Authors:  Sergei A Kuznetsov; Mahesh H Mankani; Paolo Bianco; Pamela G Robey
Journal:  Stem Cell Res       Date:  2008-08-12       Impact factor: 2.020

8.  Metabolic plasticity in stem cell homeostasis and differentiation.

Authors:  Clifford D L Folmes; Petras P Dzeja; Timothy J Nelson; Andre Terzic
Journal:  Cell Stem Cell       Date:  2012-11-02       Impact factor: 24.633

9.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells.

Authors:  Warren L Grayson; Feng Zhao; Bruce Bunnell; Teng Ma
Journal:  Biochem Biophys Res Commun       Date:  2007-05-22       Impact factor: 3.575

Review 10.  Hypoxia and stem cell-based engineering of mesenchymal tissues.

Authors:  Teng Ma; Warren L Grayson; Mirjam Fröhlich; Gordana Vunjak-Novakovic
Journal:  Biotechnol Prog       Date:  2009 Jan-Feb
View more
  19 in total

1.  Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment.

Authors:  Xuegang Yuan; Jens T Rosenberg; Yijun Liu; Samuel C Grant; Teng Ma
Journal:  Cytotherapy       Date:  2019-09-17       Impact factor: 5.414

2.  Engineering Brain-Specific Pericytes from Human Pluripotent Stem Cells.

Authors:  Richard Jeske; Jonathan Albo; Mark Marzano; Julie Bejoy; Yan Li
Journal:  Tissue Eng Part B Rev       Date:  2020-08       Impact factor: 6.389

3.  Measurement of oxygen tension within mesenchymal stem cell spheroids.

Authors:  Kaitlin C Murphy; Ben P Hung; Stephen Browne-Bourne; Dejie Zhou; Jessica Yeung; Damian C Genetos; J Kent Leach
Journal:  J R Soc Interface       Date:  2017-02       Impact factor: 4.118

4.  Assessment of Enrichment of Human Mesenchymal Stem Cells Based on Plasma and Mitochondrial Membrane Potentials.

Authors:  Timothy Kamaldinov; Josh Erndt-Marino; Michael Levin; David L Kaplan; Mariah S Hahn
Journal:  Bioelectricity       Date:  2020-03-18

Review 5.  Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells.

Authors:  Darwin J Prockop
Journal:  Matrix Biol       Date:  2016-01-22       Impact factor: 11.583

Review 6.  Metabolomic Applications in Stem Cell Research: a Review.

Authors:  Daniela S C Bispo; Catarina S H Jesus; Inês M C Marques; Katarzyna M Romek; Mariana B Oliveira; João F Mano; Ana M Gil
Journal:  Stem Cell Rev Rep       Date:  2021-06-16       Impact factor: 5.739

7.  Single-Cell Transcriptome Analysis of Human Adipose-Derived Stromal Cells Identifies a Contractile Cell Subpopulation.

Authors:  Elize Wolmarans; Juanita Mellet; Chrisna Durandt; Fourie Joubert; Michael S Pepper
Journal:  Stem Cells Int       Date:  2021-04-28       Impact factor: 5.443

8.  Identifying Biomarkers of Wharton's Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect.

Authors:  Benoît Laflaquière; Gabrielle Leclercq; Chandarong Choey; Jingkui Chen; Sabine Peres; Caryn Ito; Mario Jolicoeur
Journal:  Metabolites       Date:  2018-02-24

9.  The Suppression of Medium Acidosis Improves the Maintenance and Differentiation of Human Pluripotent Stem Cells at High Density in Defined Cell Culture Medium.

Authors:  Weiwei Liu; Zhili Ren; Kai Lu; Chengcheng Song; Edwin Chong Wing Cheung; Zhou Zhou; Guokai Chen
Journal:  Int J Biol Sci       Date:  2018-04-05       Impact factor: 6.580

10.  A molecular classification of human mesenchymal stromal cells.

Authors:  Florian Rohart; Elizabeth A Mason; Nicholas Matigian; Rowland Mosbergen; Othmar Korn; Tyrone Chen; Suzanne Butcher; Jatin Patel; Kerry Atkinson; Kiarash Khosrotehrani; Nicholas M Fisk; Kim-Anh Lê Cao; Christine A Wells
Journal:  PeerJ       Date:  2016-03-24       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.